Literature DB >> 7754371

Control of proton sensitivity of the NMDA receptor by RNA splicing and polyamines.

S F Traynelis1, M Hartley, S F Heinemann.   

Abstract

The function of the N-methyl-D-aspartate (NMDA)-preferring glutamate receptor can be regulated by extracellular pH, a process that may be important during ischemia in the brain or during seizures. Protons inhibit NMDA receptor function by 50 percent at pH 7.3 through interactions with the NR1 subunit, and both polyamines and NR1 exon 5 potentiate receptor function through relief of the tonic proton inhibition present at physiological pH. A single amino acid (lysine 211) was identified that mediates the effects of exon 5 in the rat brain. Electroneutral substitutions at this position restored pH sensitivity and, consequently, polyamine relief of tonic inhibition. This effect, together with the structural similarities between polyamines and the surface loop encoded by exon 5, suggest that exon 5 may act as a tethered pH-sensitive constitutive modulator of NMDA receptor function.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7754371     DOI: 10.1126/science.7754371

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  120 in total

1.  Molecular determinants of coordinated proton and zinc inhibition of N-methyl-D-aspartate NR1/NR2A receptors.

Authors:  C M Low; F Zheng; P Lyuboslavsky; S F Traynelis
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

2.  Crystal structure of the glutamate receptor GluA1 N-terminal domain.

Authors:  Guorui Yao; Yinong Zong; Shenyan Gu; Jie Zhou; Huaxi Xu; Irimpan I Mathews; Rongsheng Jin
Journal:  Biochem J       Date:  2011-09-01       Impact factor: 3.857

Review 3.  Glucocorticoid and polyamine interactions in the plasticity of glutamatergic synapses that contribute to ethanol-associated dependence and neuronal injury.

Authors:  Mark A Prendergast; Patrick J Mulholland
Journal:  Addict Biol       Date:  2011-10-04       Impact factor: 4.280

Review 4.  Glutamate receptor ion channels: structure, regulation, and function.

Authors:  Stephen F Traynelis; Lonnie P Wollmuth; Chris J McBain; Frank S Menniti; Katie M Vance; Kevin K Ogden; Kasper B Hansen; Hongjie Yuan; Scott J Myers; Ray Dingledine
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

Review 5.  Control of assembly and function of glutamate receptors by the amino-terminal domain.

Authors:  Kasper B Hansen; Hiro Furukawa; Stephen F Traynelis
Journal:  Mol Pharmacol       Date:  2010-07-21       Impact factor: 4.436

6.  A subunit-selective potentiator of NR2C- and NR2D-containing NMDA receptors.

Authors:  Praseeda Mullasseril; Kasper B Hansen; Katie M Vance; Kevin K Ogden; Hongjie Yuan; Natalie L Kurtkaya; Rose Santangelo; Anna G Orr; Phuong Le; Kimberly M Vellano; Dennis C Liotta; Stephen F Traynelis
Journal:  Nat Commun       Date:  2010-10-05       Impact factor: 14.919

7.  GluN1 splice variant control of GluN1/GluN2D NMDA receptors.

Authors:  Katie M Vance; Kasper B Hansen; Stephen F Traynelis
Journal:  J Physiol       Date:  2012-05-28       Impact factor: 5.182

8.  Context-dependent GluN2B-selective inhibitors of NMDA receptor function are neuroprotective with minimal side effects.

Authors:  Hongjie Yuan; Scott J Myers; Gordon Wells; Katherine L Nicholson; Sharon A Swanger; Polina Lyuboslavsky; Yesim A Tahirovic; David S Menaldino; Thota Ganesh; Lawrence J Wilson; Dennis C Liotta; James P Snyder; Stephen F Traynelis
Journal:  Neuron       Date:  2015-02-26       Impact factor: 17.173

9.  Multiple sites of action of neomycin, Mg2+ and spermine on the NMDA receptors of rat hippocampal CA1 pyramidal neurones.

Authors:  W Y Lu; Z G Xiong; B A Orser; J F MacDonald
Journal:  J Physiol       Date:  1998-10-01       Impact factor: 5.182

Review 10.  Misregulation of alternative splicing causes pathogenesis in myotonic dystrophy.

Authors:  N Muge Kuyumcu-Martinez; Thomas A Cooper
Journal:  Prog Mol Subcell Biol       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.